Many men with low levels could be spared from invasive procedures and frequent testing ...

NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

* Higher PSA levels at 65-69 linked to greater prostate cancer mortality after 70 * 80% of prostate cancer deaths after age 70 occurred in men with PSA (and) #8805;2.0 ng/mL //at 65-69 * Low PSA ...

Credit: Getty Images Recent study raises questions about the use of MRI as a first-line screening test. A ‘non-negligible’ number of men with PSA levels of 1.8 or higher but less than 3.0 ng/mL harbor ...

Men treated with darolutamide for nonmetastatic castration-resistant prostate cancer who achieve a PSA level less than 0.2 ng/mL vs higher levels have a decreased risk for radiologic progression.

NEW YORK (Reuters Health) - Men with long-term diabetes may have a reduced risk of prostate cancer, according to the results of a study published in the American Journal of Epidemiology. "Recent ...

As little as 1 mg/day of finasteride can seriously distort results of prostate-specific antigen (PSA) testing, a study shows. That’s the dosage of Propecia used by more than 4 million men to treat ...

Prostate-specific antigen (PSA) is a protein made by the prostate gland. A high PSA level could be a sign of an enlarged prostate, inflammation called prostatitis, or prostate cancer. The PSA test ...